Literature DB >> 11953403

A superoxide-hypersusceptible Salmonella enterica serovar Typhimurium mutant is attenuated but regains virulence in p47(phox-/-) mice.

Angela van Diepen1, Tahar van der Straaten, Steven M Holland, Riny Janssen, Jaap T van Dissel.   

Abstract

Salmonella enterica serovar Typhimurium is a gram-negative, facultative intracellular pathogen that predominantly invades mononuclear phagocytes and is able to establish persistent infections. One of the innate defense mechanisms of phagocytic cells is the production of reactive oxygen species, including superoxide. S. enterica serovar Typhimurium has evolved mechanisms to resist such radicals, and these mechanisms could be decisive in its ability to survive and replicate within macrophages. Recently, we described a superoxide-hypersusceptible S. enterica serovar Typhimurium mutant strain, DLG294, that carries a transposon in sspJ, resulting in the lack of expression of SspJ, which is necessary for resistance against superoxide and replication within macrophages. Here we show that DLG294, which is a 14028s derivative, hardly induced any granulomatous lesions in the livers upon subcutaneous infection of C3H/HeN (Ity(r)) mice with 3 x 10(4) bacteria and that its bacterial counts were reduced by 3 log units compared to those of wild-type S. enterica serovar Typhimurium 14028s on day 5 after infection. In contrast, DLG294 replicated like wild-type S. enterica serovar Typhimurium 14028s and induced a phenotypically similar liver pathology in p47(phox-/-) mice, which are deficient in the p47(phox) subunit of the NADPH oxidase complex and which do not produce superoxide. Consistent with these results, DLG294 reached bacterial counts identical to those of wild-type S. enterica serovar Typhimurium 14028s in bone marrow-derived macrophages from p47(phox-/-) mice and in X-CGD PLB-985 cells at 24 h after challenge. These results indicate that SspJ plays a role in the bacterium's resistance to oxidative stress and in the survival and replication of S. enterica serovar Typhimurium both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953403      PMCID: PMC127934          DOI: 10.1128/IAI.70.5.2614-2621.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Pleiotropic effects of the Bcg gene: III. Respiratory burst in Bcg-congenic macrophages.

Authors:  M Denis; A Forget; M Pelletier; E Skamene
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

2.  Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane.

Authors:  A Gallois; J R Klein; L A Allen; B D Jones; W M Nauseef
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

3.  NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease.

Authors:  H Kono; I Rusyn; M Yin; E Gäbele; S Yamashina; A Dikalova; M B Kadiiska; H D Connor; R P Mason; B H Segal; B U Bradford; S M Holland; R G Thurman
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

4.  Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases.

Authors:  F C Fang; M A DeGroote; J W Foster; A J Bäumler; U Ochsner; T Testerman; S Bearson; J C Giárd; Y Xu; G Campbell; T Laessig
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

5.  Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase.

Authors:  A Vazquez-Torres; Y Xu; J Jones-Carson; D W Holden; S M Lucia; M C Dinauer; P Mastroeni; F C Fang
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

6.  Novel Salmonella enterica serovar Typhimurium protein that is indispensable for virulence and intracellular replication.

Authors:  T van der Straaten; A van Diepen; K Kwappenberg; S van Voorden; K Franken; R Janssen; J G Kusters; D L Granger; J T van Dissel
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes.

Authors:  P Vaudaux; F A Waldvogel
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

8.  Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent.

Authors:  P I Fields; R V Swanson; C G Haidaris; F Heffron
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

9.  Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo.

Authors:  P Mastroeni; A Vazquez-Torres; F C Fang; Y Xu; S Khan; C E Hormaeche; G Dougan
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

10.  In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes.

Authors:  E H Burger; J W Van der Meer; J S van de Gevel; J C Gribnau; G W Thesingh; R van Furth
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

Review 2.  Bacterial manipulation of innate immunity to promote infection.

Authors:  Lautaro Diacovich; Jean-Pierre Gorvel
Journal:  Nat Rev Microbiol       Date:  2010-02       Impact factor: 60.633

3.  Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/- mice.

Authors:  Elaine Bignell; Susana Negrete-Urtasun; Ana Maria Calcagno; Herbert N Arst; Tom Rogers; Ken Haynes
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Gamma irradiation or CD4+-T-cell depletion causes reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice.

Authors:  Angela van Diepen; Joke S van de Gevel; Margaretha M Koudijs; Ferry Ossendorp; Henry Beekhuizen; Riny Janssen; Jaap T van Dissel
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Contribution of glutathione peroxidase to the virulence of Streptococcus pyogenes.

Authors:  Audrey Brenot; Katherine Y King; Blythe Janowiak; Owen Griffith; Michael G Caparon
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 6.  Genetics-squared: combining host and pathogen genetics in the analysis of innate immunity and bacterial virulence.

Authors:  Jenny Persson; Russell E Vance
Journal:  Immunogenetics       Date:  2007-09-14       Impact factor: 2.846

7.  Antioxidant Defense by Thioredoxin Can Occur Independently of Canonical Thiol-Disulfide Oxidoreductase Enzymatic Activity.

Authors:  Miryoung Song; Ju-Sim Kim; Lin Liu; Maroof Husain; Andrés Vázquez-Torres
Journal:  Cell Rep       Date:  2016-03-17       Impact factor: 9.423

8.  Salmonella enterica serovar Typhimurium RamA, intracellular oxidative stress response, and bacterial virulence.

Authors:  Tahar van der Straaten; Laurence Zulianello; Angela van Diepen; Donald L Granger; Riny Janssen; Jaap T van Dissel
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

9.  Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.

Authors:  Zhanqin Zhao; Yun Xue; Bin Wu; Xibiao Tang; Ruiming Hu; Yindi Xu; Aizhen Guo; Huanchun Chen
Journal:  Infect Immun       Date:  2008-02-11       Impact factor: 3.441

10.  Deciphering the roles of BamB and its interaction with BamA in outer membrane biogenesis, T3SS expression and virulence in Salmonella.

Authors:  Fatémeh Namdari; Genaro Alejandro Hurtado-Escobar; Nadia Abed; Jérôme Trotereau; Yann Fardini; Etienne Giraud; Philippe Velge; Isabelle Virlogeux-Payant
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.